Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by momocauon Mar 24, 2024 11:17am
83 Views
Post# 35949475

RE:Besides the $225 million wasted on Medmen, buying

RE:Besides the $225 million wasted on Medmen, buying
NOW THAT YOU HAVE SAID ALL THESE NEGATIVE THINGS ABOUT TILRAY (( EXPLAINS TO INVESTORS WHY THE STOCKS ARE GOING UP LIKE THIS )) ITS PROVE THAT THE CEO'S DECISIONS WERE THE RIGHT ONE. CONTINUE YOUR GREAT WORK, MORE THAN YOU PUBLISH OUR ACTIONS ARE ON THE GREAT. WE CAN SEE THAT YOU ARE PAID TO DENIGRATE TILRAY
2024 IS GOING TO BE THE YEAR OF TILRAY.
GOOD LUCK TO ALL OF YOU, TILRAY INVESTORS.
<< Previous
Bullboard Posts
Next >>